Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.7801
-0.0079 (-1.00%)
At close: Apr 27, 2026, 4:00 PM EDT
0.7958
+0.0157 (2.01%)
After-hours: Apr 27, 2026, 7:38 PM EDT
Evogene Market Cap
Evogene has a market cap or net worth of $9.67 million as of April 27, 2026. Its market cap has increased by 6.18% in one year.
Market Cap
9.67M
Enterprise Value
11.06M
1-Year Change
6.18%
Ranking
Category
Stock Price
$0.78
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $9.67M, a decrease of -65.47%. That is a compound annual growth rate of -5.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 9.92M | 20.66% |
| Dec 31, 2025 | 8.22M | -36.78% |
| Dec 31, 2024 | 13.00M | -69.10% |
| Dec 31, 2023 | 42.08M | 60.85% |
| Dec 29, 2022 | 26.16M | -63.27% |
| Dec 30, 2021 | 71.23M | -58.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lunai Bioworks | 11.25M |
| Imunon | 10.94M |
| Aprea Therapeutics | 10.65M |
| Kiora Pharmaceuticals | 10.31M |
| Quoin Pharmaceuticals | 10.28M |
| Enveric Biosciences | 10.01M |
| GT Biopharma | 9.86M |
| Genprex | 9.39M |